Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph A Defronzo

Showing results (101-110 of 313) with videos related to

Pageof 32
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|June 25, 2026
Under- and overdosing insulin in the hospital: A retrospective cohort study of dose deviation and patient outcomesHussein Zaitoon, Sher Matsri, Shira Nagler, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysisEle Ferrannini, Amalia Gastaldelli, Masafumi Matsuda, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2005
The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetesAmalia Gastaldelli, Yoshinori Miyazaki, Maura Pettiti, et al.
Diabetes Care|January 29, 2010
Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metforminRalph A DeFronzo, Curtis Triplitt, Yongming Qu, et al.
World Journal of Diabetes|April 20, 2013
Parental transmission of type 2 diabetes mellitus in a highly endogamous populationAbdulbari Bener, Mohammad T Yousafzai, Abdulla Oaa Al-Hamaq, et al.
Endocrinology, Diabetes & Metabolism|March 1, 2019
Glucose lowering and vascular protective effects of cycloset added to GLP-1 receptor agonists in patients with type 2 diabetesMariam Alatrach, Christina Agyin, John Adams, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 10, 2006
Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individualsMerri Pendergrass, Alessandra Bertoldo, Riccardo Bonadonna, et al.
Diabetes|January 29, 2005
Identification of individuals with insulin resistance using routine clinical measurementsSteven E Stern, Ken Williams, Eleuterio Ferrannini, et al.
Diabetes, Obesity & Metabolism|July 31, 2020
Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar studyMuhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, et al.
BMC Medicine|September 3, 2024
Advances and counterpoints in type 2 diabetes. What is ready for translation into real-world practice, ahead of the guidelinesStanley S Schwartz, Barbara E Corkey, James R Gavin, et al.
Pageof 32

Showing results (101-110 of 313) with videos related to

Sort By:
Pageof 32
Diabetic Medicine : a Journal of the British Diabetic Association|June 25, 2026
Under- and overdosing insulin in the hospital: A retrospective cohort study of dose deviation and patient outcomesHussein Zaitoon, Sher Matsri, Shira Nagler, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysisEle Ferrannini, Amalia Gastaldelli, Masafumi Matsuda, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2005
The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetesAmalia Gastaldelli, Yoshinori Miyazaki, Maura Pettiti, et al.
Diabetes Care|January 29, 2010
Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metforminRalph A DeFronzo, Curtis Triplitt, Yongming Qu, et al.
World Journal of Diabetes|April 20, 2013
Parental transmission of type 2 diabetes mellitus in a highly endogamous populationAbdulbari Bener, Mohammad T Yousafzai, Abdulla Oaa Al-Hamaq, et al.
Endocrinology, Diabetes & Metabolism|March 1, 2019
Glucose lowering and vascular protective effects of cycloset added to GLP-1 receptor agonists in patients with type 2 diabetesMariam Alatrach, Christina Agyin, John Adams, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 10, 2006
Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individualsMerri Pendergrass, Alessandra Bertoldo, Riccardo Bonadonna, et al.
Diabetes|January 29, 2005
Identification of individuals with insulin resistance using routine clinical measurementsSteven E Stern, Ken Williams, Eleuterio Ferrannini, et al.
Diabetes, Obesity & Metabolism|July 31, 2020
Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar studyMuhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, et al.
BMC Medicine|September 3, 2024
Advances and counterpoints in type 2 diabetes. What is ready for translation into real-world practice, ahead of the guidelinesStanley S Schwartz, Barbara E Corkey, James R Gavin, et al.
Pageof 32